Werbung
Werbung
IBIO
iBio, Inc. Common Stock
2.69
USDGesponsert
+0.34
+14.38%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
2.67
-0.02
-0.86%
IBIO Ergebnisberichte
Positives Überraschungsverhältnis
IBIO übertreffen die 7 der letzten 17Schätzungen.
41%
Nächster Bericht
Datum des nächsten Berichts
09. Feb. 2026
Estimate for Q2 26 (Revenue/ EPS)
$34.00K
/-$0.09
Implizierte Änderung von Q1 26 (Revenue/ EPS)
-66.00%
/-18.18%
Implizierte Änderung von Q2 25 (Revenue/ EPS)
-83.00%
/-81.25%
iBio, Inc. Common Stock earnings per share and revenue
On 12. Nov. 2025, IBIO reported earnings of -0.11 USD per share (EPS) for Q1 26, missing the estimate of -0.10 USD, resulting in a -5.16% surprise. Revenue reached 100.00 tausend, compared to an expected 25.50 tausend, with a 292.16% difference. The market reacted with a -8.00% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 6 analysts forecast an EPS of -0.09 USD, with revenue projected to reach 34.00 tausend USD, implying an decrease of -18.18% EPS, and decrease of -66.00% in Revenue from the last quarter.
FAQ
What were iBio, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, iBio, Inc. Common Stock reported EPS of -$0.11, missing estimates by -5.16%, and revenue of $100.00K, 292.16% above expectations.
How did the market react to iBio, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -8%, changed from $1.25 before the earnings release to $1.15 the day after.
When is iBio, Inc. Common Stock expected to report next?
The next earning report is scheduled for 09. Feb. 2026.
What are the forecasts for iBio, Inc. Common Stock's next earnings report?
Based on 6
analysts, iBio, Inc. Common Stock is expected to report EPS of -$0.09 and revenue of $34.00K for Q2 2026.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung